Picture EBD Group Global Partnering Four Events One Price 650x80
Document › Details

Bicycle Therapeutics plc. (8/1/19). "Press Release: Bicycle Therapeutics to Present at the Canaccord Genuity 39th Annual Growth Conference". Cambridge & Boston, MA.

Region Region Boston, MA
  Country United States (USA)
Organisations Organisation Bicycle Therapeutics plc (Nasdaq: BCYC)
  Group Bicycle Therapeutics (Group)
  Organisation 2 Canaccord Genuity (Group)
Products Product Canaccord Genuity Annual Growth Conference 2019 Boston
  Product 2 Bicycle Drug Conjugates®
Index term Index term Bicycle Therapeutics–Canaccord Genuity: investor conference, 201908 supply service Bicycle presents at Canaccord Genuity Growth Conference in Boston
Person Person Green, Sara (Ten Bridge Communications 201908)

Bicycle Therapeutics plc, a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced that management will present at the Canaccord Genuity 39th Annual Growth Conference on Wednesday, August 7, 2019 at 1:30 p.m. EDT in Boston, MA.

A live webcast of the presentation can be accessed in the Investors & Media section of Bicycle’s website at An archived replay of the webcast will be available for 90 days following the presentation date.

About Bicycle Therapeutics

Bicycle Therapeutics plc (NASDAQ: BCYC) is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycles®, for diseases that are underserved by existing therapeutics. Bicycles are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. This constraint facilitates target binding with high affinity and selectivity, making Bicycles attractive candidates for drug development. Bicycle’s lead product candidate, BT1718, is a Bicycle Toxin Conjugate being investigated in an ongoing Phase I/IIa clinical trial in collaboration with the Centre for Drug Development of Cancer Research UK. Bicycle is headquartered in Cambridge, U.K. with many key functions and members of its leadership team located in Lexington, MA. For more information, visit, connect with us on LinkedIn and follow us on Twitter at @Bicycle_tx.

Ten Bridge Communications
Sara Green

Argot Partners
Maeve Conneighton

Record changed: 2019-08-22


Picture EBD Group Global Partnering Four Events One Price 650x80

More documents for Bicycle Therapeutics (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture [iito] Back into Ad 650x80px

» top